Ependymoma
📧 Sign up to get email alerts when something new happens for Ependymoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas [Phase 1, Phase 2]
Clinical trial update on proton beam radiation therapy for various adult brain tumors, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma [Phase 2]
A Phase 2 trial evaluating bevacizumab and lapatinib in children with recurrent or refractory ependymoma has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma [Phase 2]
Phase 2 trial update on risk-adapted therapy for young children with embryonal brain tumors, choroid plexus carcinoma, high-grade glioma, or…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children [Phase 2, Phase 3]
This document is an update on a Phase 2/Phase 3 therapy optimization trial for relapsed or refractory pediatric brain tumors, which has comp…
-
CLINICAL_TRIALS research · 2018-07-16Clinical Trial Update: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
This clinical trial update describes the collection and storage of blood and brain tumor tissue samples from children with brain tumors for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Yoga Therapy in Treating Patients With Malignant Brain Tumors [NA]
This entry notes a terminated clinical trial at Wake Forest evaluating yoga therapy for adults with malignant brain tumors.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor [Phase 1]
Phase 1 trial evaluating autologous dendritic cells loaded with brain tumor stem cells for progressive malignant brain tumors has completed.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]
A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma [Phase 2]
Phase 2 trial evaluating observation or radiation therapy and/or chemotherapy and a second surgery in children after initial surgery for epe…
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas [EARLY_Phase 1]
Early-phase trial evaluating autologous stem cell collection and reinfusion in newly diagnosed high-grade gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Ependymoma [Phase 2]
Phase 2 trial update on antineoplaston therapy for ependymoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors [Phase 1]
Phase 1 study of AZD2171 (cediranib) in children with recurrent, progressive, or refractory primary central nervous system tumors has comple…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma [Phase 1]
This clinical trial update reports the completion of a Phase I study evaluating 5-fluorouracil in children and young adults with recurrent e…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 [Phase 2]
This is a Phase 2 trial update for single-agent erlotinib in ependymoma patients previously treated with oral etoposide (OSI-774-205); the s…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma [Phase 2]
The Phase 2 trial evaluating carboplatin as a radiosensitizer for childhood ependymoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 study of RO4929097, a gamma-secretase inhibitor, in pediatric patients with relapsed or refractory solid tumors, CNS tumors, lymphom…
-
CLINICAL_TRIALS other · 2014-01-28Clinical Trial Update: Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma [NA]
This clinical trial update indicates completion of a study on radiation therapy with combination chemotherapy for young patients with medull…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma [Phase 2]
Phase 2 trial comparing erlotinib to oral etoposide in pediatric ependymoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [Phase 1]
This Phase 1 trial evaluates the combination of temozolomide and O6-benzylguanine in pediatric patients with recurrent brain tumors.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Phase 1]
A Phase 1 clinical trial evaluated lenalidomide in young patients with recurrent, progressive, or refractory central nervous system tumors. …
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Cilengitide in Treating Children With Refractory Primary Brain Tumors [Phase 1]
Phase 1 trial of cilengitide in children with refractory primary brain tumors has completed; the study explored safety, dosing, and tolerabi…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Clinical trial update on young patients with ependymoma undergoing standard combination chemotherapy; the study is currently active but not …
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma [Phase 2]
A Phase 2 clinical trial evaluating high-dose methotrexate in young patients with residual ependymoma is described (status not reported).
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma [Phase 2]
This is a Phase 2 trial update for treating localized ependymoma in children with combination chemotherapy followed by radiation therapy. Th…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Etoposide in Treating Young Patients With Relapsed Ependymoma [Phase 2]
This clinical trial update describes a Phase 2 study of etoposide for relapsed ependymoma in young patients. The current trial status is lis…